Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301534 · ClinicalTrials.gov registry record
Comparison of Methods to Improve Abdominal Aortic Aneurysm (AAA) Screening Rates in the Primary Care Setting.
A clinical trial of Abdominal Aortic Aneurysm, sponsored by Mike O'Callaghan Military Hospital.
- Completed
- Registry status
- 1,700
- Enrollment target
- 1
- Study location
NCT01301534 is a study of Abdominal Aortic Aneurysm that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 1,700 participants, above the 348-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (389% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01301534, a study of Abdominal Aortic Aneurysm, has completed, sponsored by Mike O'Callaghan Military Hospital.
- COMPLETED
- Registry status
- 1,700 participants
- Enrollment target
- 1
- Study location
Study Summary
Standard of care dictates that eligible patients should receive an abdominal aortic aneurysm (AAA) screening ultrasound. At present, different military primary care physicians utilize different methods at their discretion to ensure their patients get screened-telephone contact; mail-out reminders; referring patients for ultrasound directly from an office visit; as well as other methods-which we will refer to as "usual care". The purpose of this study is to improve screening rates for AAA and determine what notification methods are best at improving screening rates.
Conditions Studied
Study Locations (1)
Nevada
- Michael O'Callaghan Federal Hospital/Nellis Air Force Base - Nellis Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01301534
The ClinicalTrials.gov registry entry for NCT01301534 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 348-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (389% higher). The listed sponsor is Mike O'Callaghan Military Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT01301534 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT01301534 about?
NCT01301534 is a clinical study titled "Comparison of Methods to Improve Abdominal Aortic Aneurysm (AAA) Screening Rates in the Primary Care Setting.". Standard of care dictates that eligible patients should receive an abdominal aortic aneurysm (AAA) screening ultrasound. At present, different military primary care physicians utilize different methods at their discretion to ensure their patients get screened-telephone contact; mail-out reminders; r...
What is the current status of trial NCT01301534?
This trial is currently completed. The enrollment target is 1,700 participants. The study started on 2010-12. Estimated completion is 2012-06.
What conditions does trial NCT01301534 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
Who is sponsoring clinical trial NCT01301534?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01301534 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
Limiting AAA With Metformin (LIMIT) Trial
RECRUITING · Phase 2
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Nectero EAST System Clinical Study
RECRUITING · Phase 2
-
PET Imaging of MMP Activation in AAA: Clinical Component
RECRUITING · Early Phase 1
-
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.